Veracyte (VCYT) Tops Q4 EPS by 7c, Revenues Beat; Offers FY19 Revenue Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/23/2026

1. KBH
2. PATH
3. AZO
4. SPY
5. PLTR
6. RCL
7. ONON
8. QQQ
9. PRGS
10. ORCL

Go back to Veracyte (VCYT) Tops Q4 EPS by 7c, Revenues Beat; Offers FY19 Revenue Guidance Above Consensus

Veracyte Announces Fourth Quarter and Full-Year 2018 Financial Results and Provides 2019 Financial Outlook

February 25, 2019 4:15 PM EST

2018 Revenue Grew 28% to $92 million

Three Commercial Products and Biopharma Collaborations to Drive Growth in 2019

Company to Host Conference Call and Webcast Today at 5:00 p.m. ET

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (Nasdaq: VCYT) today announced financial results and business progress for the quarter and full year ended... More